GLP-1 medications have become one of the most talked-about developments in prescription weight loss over the past two years
None of this is surprising for an unregulated supplement with no proven mechanism of action
Demand Outlook for GLP-1 Nutritional Support Market in the United States The CAGR of the GLP-1 nutritional support market in the United States rose from approximately 8.2% during 2020 to 2024 to 11.2% for 2025 to 2035, supported by stronger insurance reimbursement frameworks and physician adoption across outpatient metabolic care
People taking GLP-1 medications commonly report reduced food cravings, less emotional eating, and a quieting of the constant mental preoccupation with food that researchers call "food noise." Animal studies have also shown that GLP-1 receptor activation reduces the rewarding properties of high-calorie food in the brain findings confirmed in a landmark randomized, placebo-controlled neuroimaging study in humans ( van Bloemendaal et al., Diabetes, 2014 )
I want something that's going to help me develop and grow as a person. Cochran wants to get his ball handling a little tighter and continue getting leaner as he enters his final season of high school basketball with the Perkiomen School
Genetics 48 HendersonS
